Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives.
This research will apply the algorithm diet and the findings from the Israeli and Mayo clinic studies to a target population of adults with type 2 diabetes whose A1C is between 7-10%. The intervention diet will be compared to traditional medical nutrition therapy. Outcome measures include looking at changes in both A1C and TIR (time in range).